RRS HA Eyes 12x1.5ml
Important Notice
Regulated medical device (EU MDR 2017/745). For sale exclusively to qualified healthcare professionals.
What this purchase includes
- Original productFrom the manufacturer or an official distributor, CE marked.
- Batch and expiry documentedRecorded per unit on the delivery note and the invoice.
- Controlled storageOur own Madrid warehouse, 12 to 18 °C under 24 h control.
- Dispatch in 24 to 48 hFrom Madrid, insured and with a tracking number.
- Reachable Monday to Friday9:00 to 17:00 by WhatsApp and email. People, not forms.
RRS® HA Eyes is the formulation of the RRS® range from Skin Tech Pharma Group developed specifically for the periocular contour: non-cross-linked hyaluronic acid at 5.0 mg/ml (7.5 mg per 1.5 ml ampoule) dissolved in a protective buffer with organic silicon, antioxidants, flavonoids, saponins, polyphenols and peptides. The reduced ampoule volume corresponds to the small doses required by the area.
- Non-cross-linked HA 5.0 mg/ml
- Per ampoule 7.5 mg / 1.5 ml
- Contents 12 ampoules × 1.5 ml
- Area eye contour
- Medical device class III
Composition and technology
Non-cross-linked hyaluronic acid: 5.0 mg/ml, equivalent to 7.5 mg per 1.5 ml ampoule.
Protective buffer: the manufacturer declares the following groups of actives, without publishing individual concentrations:
- Organic silicon
- Antioxidants
- Flavonoids
- Saponins
- Polyphenols
- Peptides
Non-cross-linked hyaluronic acid does not provide structural volume: it acts as a hydrating vehicle and as a carrier for the complex of actives in the superficial dermis of an area of particularly thin skin.
Position within the RRS® range
| RRS® HA Eyes | Non-cross-linked HA 5.0 mg/ml (7.5 mg / 1.5 ml) — eye contour — 12 ampoules × 1.5 ml |
|---|---|
| RRS® HA Injectable | Non-cross-linked HA 6.0 mg/ml (30 mg / 5 ml), 72 actives — face and body — 6 vials × 5 ml |
| RRS® Hyalift® 75 | Non-cross-linked HA 15.0 mg/ml (75 mg / 5 ml), amino acid buffer — face and body — 6 vials × 5 ml |
| RRS® Hyalift® 75 PROactive | Non-cross-linked HA 15.0 mg/ml + polyphenols and antioxidants — face and body — 6 vials × 5 ml |
| RRS® HA Long Lasting | HA cross-linked with BDDE 21 mg / 3 ml — 3 ml syringe |
| XL Hair® | HA 0.001 mg/ml + FGF, GM peptide, sodium DNA — scalp — 6 vials × 5 ml |
Within the range, HA Eyes is the only reference formulated and packaged for the periocular region; its hyaluronic acid concentration is intermediate between HA Injectable and the Hyalift variants.
Indications and treatment areas
Indications declared by the manufacturer: reduction of the puffy appearance of the periocular area, smoothing of the eye contour and improvement of skin elasticity.
- Periocular region
- Temporal area
- Infraorbital bags
- Dark circles
Technique and treatment protocol
Injectable medical device intended for intradermal administration by microinjections in the periocular area, on healthy, disinfected skin, under aseptic conditions.
The manufacturer does not publish in its public documentation the needle gauge, the dose per point or the number of sessions for this reference. The applicable protocol is the one set out in the instructions for use supplied with the pack and in the manufacturer's training.
Technical data
| Manufacturer | Skin Tech Pharma Group S.L.U., Spain |
|---|---|
| Active substance | Non-cross-linked hyaluronic acid 5.0 mg/ml |
| Content per ampoule | 7.5 mg of HA in 1.5 ml |
| Protective buffer | Organic silicon, antioxidants, flavonoids, saponins, polyphenols, peptides |
| Presentation | Box of 12 ampoules of 1.5 ml |
| Route of administration | Injectable — intradermal |
| Classification | CE-marked sterile class III medical device |
| Use | Medical use only, in a legally authorised centre |
Storage and pack contents
- Box of 12 sterile ampoules of 1.5 ml.
- Sterile single-use product. Do not reuse or re-sterilise.
- Store as indicated on the pack, protected from direct sunlight.
- Do not use after the expiry date stated on the pack.
Contraindications and warnings
Known hypersensitivity to any of the components; active infection, inflammation or skin lesion in the treatment area; coagulation disorders; autoimmune diseases; pregnancy and breastfeeding; under 18 years of age.
The manufacturer expressly states that the product may only be injected by a legally qualified physician in a legally authorised centre. Always consult the instructions for use included in the pack before treatment.
Medical device intended exclusively for qualified healthcare professionals. Technical information based on the official documentation of Skin Tech Pharma Group. This information sheet does not replace the instructions for use supplied with the product.